J. Goldman & Co LP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2020$2,448,000
-22.2%
238,617
+649.7%
0.12%
-24.8%
Q4 2017$3,146,000
+60.2%
31,829
+94.1%
0.16%
+66.7%
Q3 2017$1,964,000
-4.1%
16,400
-70.2%
0.10%
-2.9%
Q1 2017$2,049,000
-38.3%
55,102
+11.3%
0.10%
-45.5%
Q3 2016$3,319,00049,5000.19%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders